"Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources and support, ...

About half of people with "chronic spontaneous urticaria," or CSU, the most common type of chronic hives, experience what ...

Diagnosing CSU can be difficult for a few main reasons, including the following: CSU is often misdiagnosed because hives are ...

It can transition into chronic urticaria for up to 8% of the population. Hives tend to go away without treatment, but self-care strategies like taking a cooling bath can help manage discomfort. Some ...

MCLEAN, VA / ACCESSWIRE / December 10, 2024 / Dr. Amir Bajoghli and his colleagues have recently published an insightful case ...

is defined as the occurrence of hives, angioedema, or both, lasting for more than 6 weeks. The treatment is based on the use of antihistamines, omalizumab, and/or cyclosporine following a stepwise ...

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...

Treatment is difficult, involving fluid replacement and C1 esterase inhibitor concentrate for acute attacks (not approved in the U.S.) and prophylactic treatment with anabolic androgens and ...

Urticaria affects 10% to 25% of the population at some point in their life (Henderson, Fleischer, & Feldman, 2000). It is characterized by short-lived swellings of the skin, mouth, and genitalia ...

to treat adults and pediatric patients aged 12 years and older with chronic spontaneous urticaria (CSU) whose disease is not adequately controlled with H1 antihistamine treatment. The target ...

A new approach to treat rosacea and other inflammatory skin conditions could be on the horizon, according to a University of ...